In addition, Strojnik et al. [46] demonstrated that nestin has a significant impact on survival for patients with GBM, whereas Annovazi et al. [48] confirmed a correlation between stem cell marker SOX2 expression and glioma malignancy grade. This evidence concerns the gene SOX2 and glioblastoma.